BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23029087)

  • 1. Post-transplant immunosuppression: regulation of the efflux of allospecific effector T cells from lymphoid tissues.
    Swan DJ; Kirby JA; Ali S
    PLoS One; 2012; 7(9):e45548. PubMed ID: 23029087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired T-cell responses to sphingosine-1-phosphate in HIV-1 infected lymph nodes.
    Mudd JC; Murphy P; Manion M; Debernardo R; Hardacre J; Ammori J; Hardy GA; Harding CV; Mahabaleshwar GH; Jain MK; Jacobson JM; Brooks AD; Lewis S; Schacker TW; Anderson J; Haddad EK; Cubas RA; Rodriguez B; Sieg SF; Lederman MM
    Blood; 2013 Apr; 121(15):2914-22. PubMed ID: 23422746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamin 2-dependent endocytosis is required for sustained S1PR1 signaling.
    Willinger T; Ferguson SM; Pereira JP; De Camilli P; Flavell RA
    J Exp Med; 2014 Apr; 211(4):685-700. PubMed ID: 24638168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD69 does not affect the extent of T cell priming.
    Alari-Pahissa E; Notario L; Lorente E; Vega-Ramos J; Justel A; López D; Villadangos JA; Lauzurica P
    PLoS One; 2012; 7(10):e48593. PubMed ID: 23119065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD69 suppresses sphingosine 1-phosophate receptor-1 (S1P1) function through interaction with membrane helix 4.
    Bankovich AJ; Shiow LR; Cyster JG
    J Biol Chem; 2010 Jul; 285(29):22328-37. PubMed ID: 20463015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monocyte-derived S1P in the lymph node regulates immune responses.
    Baeyens A; Bracero S; Chaluvadi VS; Khodadadi-Jamayran A; Cammer M; Schwab SR
    Nature; 2021 Apr; 592(7853):290-295. PubMed ID: 33658712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclical modulation of sphingosine-1-phosphate receptor 1 surface expression during lymphocyte recirculation and relationship to lymphoid organ transit.
    Lo CG; Xu Y; Proia RL; Cyster JG
    J Exp Med; 2005 Jan; 201(2):291-301. PubMed ID: 15657295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.
    Shiow LR; Rosen DB; Brdicková N; Xu Y; An J; Lanier LL; Cyster JG; Matloubian M
    Nature; 2006 Mar; 440(7083):540-4. PubMed ID: 16525420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation.
    Martín P; Gómez M; Lamana A; Cruz-Adalia A; Ramírez-Huesca M; Ursa MA; Yáñez-Mo M; Sánchez-Madrid F
    Mol Cell Biol; 2010 Oct; 30(20):4877-89. PubMed ID: 20696842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct expression patterns of CD69 in mucosal and systemic lymphoid tissues in primary SIV infection of rhesus macaques.
    Wang X; Xu H; Alvarez X; Pahar B; Moroney-Rasmussen T; Lackner AA; Veazey RS
    PLoS One; 2011; 6(11):e27207. PubMed ID: 22096538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Egress: a receptor-regulated step in lymphocyte trafficking.
    Rosen H; Sanna G; Alfonso C
    Immunol Rev; 2003 Oct; 195():160-77. PubMed ID: 12969317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD69 down-modulation and inhibition of thymic egress by short- and long-term selective chemical agonism of sphingosine 1-phosphate receptors.
    Alfonso C; McHeyzer-Williams MG; Rosen H
    Eur J Immunol; 2006 Jan; 36(1):149-59. PubMed ID: 16342326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human intrahepatic CD69 + CD8+ T cells have a tissue resident memory T cell phenotype with reduced cytolytic capacity.
    Stelma F; de Niet A; Sinnige MJ; van Dort KA; van Gisbergen KPJM; Verheij J; van Leeuwen EMM; Kootstra NA; Reesink HW
    Sci Rep; 2017 Jul; 7(1):6172. PubMed ID: 28733665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: CD69 interference with sphingosine-1-phosphate receptor function regulates peripheral T cell retention.
    Mackay LK; Braun A; Macleod BL; Collins N; Tebartz C; Bedoui S; Carbone FR; Gebhardt T
    J Immunol; 2015 Mar; 194(5):2059-63. PubMed ID: 25624457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69.
    Srinivasan S; Bolick DT; Lukashev D; Lappas C; Sitkovsky M; Lynch KR; Hedrick CC
    Diabetes; 2008 Feb; 57(2):484-93. PubMed ID: 18003758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling.
    Saldanha-Araujo F; Haddad R; Farias KC; Souza Ade P; Palma PV; Araujo AG; Orellana MD; Voltarelli JC; Covas DT; Zago MA; Panepucci RA
    J Cell Mol Med; 2012 Jun; 16(6):1232-44. PubMed ID: 21777379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine-1-phosphate receptors control B-cell migration through signaling components associated with primary immunodeficiencies, chronic lymphocytic leukemia, and multiple sclerosis.
    Sic H; Kraus H; Madl J; Flittner KA; von Münchow AL; Pieper K; Rizzi M; Kienzler AK; Ayata K; Rauer S; Kleuser B; Salzer U; Burger M; Zirlik K; Lougaris V; Plebani A; Römer W; Loeffler C; Scaramuzza S; Villa A; Noguchi E; Grimbacher B; Eibel H
    J Allergy Clin Immunol; 2014 Aug; 134(2):420-8. PubMed ID: 24679343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD69: from activation marker to metabolic gatekeeper.
    Cibrián D; Sánchez-Madrid F
    Eur J Immunol; 2017 Jun; 47(6):946-953. PubMed ID: 28475283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of CD69 targeting on bystander and antigen-specific T cell proliferation.
    Alari-Pahissa E; Vega-Ramos J; Zhang JG; Castaño AR; Turley SJ; Villadangos JA; Lauzurica P
    J Leukoc Biol; 2012 Jul; 92(1):145-58. PubMed ID: 22544938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD69 overexpression by human T-cell leukemia virus type 1 Tax transactivation.
    Ishikawa C; Kawakami H; Uchihara JN; Senba M; Mori N
    Biochim Biophys Acta; 2013 Jun; 1833(6):1542-52. PubMed ID: 23507197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.